NetraMark combines proprietary QML/ML algorithms with cross-domain expertise to bring ML commercialization into reality, starting with the pharmaceutical space in drug development, resurrection, and disease definition. Many high-value ml problems across a broad range of industries are data-bound and traditional big data and deep learning methods offer little to no utility. Netramark is a next-generation ai platform company with a new machine learning paradigm that is designed to work with small data sets as well as offer explainability where it is needed for many regulated domains. New math for small data and explainability.
Total Funding: N/A
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2015
